home / stock / mbrx / mbrx news


MBRX News and Press, Moleculin Biotech Inc. From 04/16/20

Stock Information

Company Name: Moleculin Biotech Inc.
Stock Symbol: MBRX
Market: NASDAQ
Website: moleculin.com

Menu

MBRX MBRX Quote MBRX Short MBRX News MBRX Articles MBRX Message Board
Get MBRX Alerts

News, Short Squeeze, Breakout and More Instantly...

MBRX - INO, BBBY among premarket gainers

Edison Nation (NASDAQ: EDNT ) +169%  on over  $10M order . More news on: Edison Nation, Inc., Soligenix, Inc., Atossa Therapeutics, Inc., Stocks on the move, , Read more ...

MBRX - Moleculin to Host Investor Conference Call to Discuss COVID-19 Potential for Drug Candidate Today

HOUSTON , April 16, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates, announced that Walter Klemp , Chairman and Chief Executive Officer, will host a web-bas...

MBRX - Moleculin Announces Leading Virologist Joins Development Team

HOUSTON , April 15, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates, today announced that Dr. Dominique Schols of the Rega Institute has joined the Molecul...

MBRX - ROKU, CCL among premarket gainers today

Sonnet BioTherapeutics Holdings (NASDAQ: SONN ) +100% . More news on: Sonnet BioTherapeutics Holdings, Inc., MEI Pharma, Inc., NantKwest, Inc., Stocks on the move, Read more ...

MBRX - Moleculin Announces Investor Conference Call to Discuss COVID-19 Potential for Drug Candidate

HOUSTON , April 14, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates, today announced that Walter Klemp , Chairman and Chief Executive Officer, will host a w...

MBRX - RCL, EQX among premarket losers

AMC Entertainment Holdings (NYSE: AMC )  -17%  on potential Chapter 11 filing . More news on: AMC Entertainment Holdings, Inc., Enzo Biochem, Inc., CleanSpark, Inc., Stocks on the move, , Read more ...

MBRX - CNS Pharma up 19% premarket on development of COVID-19 candidates

Thinly traded nano cap CNS Pharmaceuticals (NASDAQ: CNSP ) jumps  19%  premarket on light volume on the heels of its announced collaboration with WPD Pharmaceuticals to develop several preclinical COVID-19 candidates, including WP112, that WPD in-licensed from Moleculin Biotech (...

MBRX - WPD Pharmaceuticals Reports Active Compound in Licensed Drug Candidate Reduces Coronavirus Replication in Vitro by 100%

VANCOUVER, British Columbia, April 09, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD” ) a clinical stage pharmaceutical company , is pleased to announce that independent research on its WP1122 drug compound ...

MBRX - NYMT, MITT, EHTH and DPW among midday movers

Gainers:  Moleculin Biotech (NASDAQ: MBRX )  +121% . More news on: Moleculin Biotech, Inc., Ellington Financial Inc., Intelsat S.A., Stocks on the move, , Read more ...

MBRX - Biotechs Fast Track Repurposing Existing Drugs for COVID-19 Treatments

April 8, 2020 Palm Beach, FL – April 8, 2020 – The search for vaccines and treatments for the global health crises is now focusing on medicines that are presently approved for other ailments. A recent article in the LA Times discussed this issue saying that when ...

Previous 10 Next 10